PENGARUH FILTER DALAM PEMBUATAN KOMPONEN DARAH PRC LEUCODEPLETED TERHADAP NILAI LEUKOSIT DI UDD PMI KABUPATEN BANDUNG
DOI:
https://doi.org/10.31004/jkt.v4i4.21761Keywords:
Komponen, Leukodepleted, PRCAbstract
PRC Leucodepleted adalah komponen darah yang dibuat melalui proses filtrasi. Pemberian komponen PRC Leucodepleted menimbulkan rekasi lebih rendah (38%) dari pada pemberian komponen darah PRC non Leucodepleted (62%). Mengetahui kualitas komponen darah PRC Leucodepleted di UDD PMI Kabupaten Bandung. Penelitian ini menggunakan jenis penelitian eksperimental dengan pendekatan kuantitatif. Penelitian dilakukan pada Desember – Mei 2023 pada 30 sampel. Cara pengumpulan data dengan menggunakan data sekunder. Analisis data yang digunakan berupa analisis bivariat dan univariat dilanjutkan dengan uji T. Hasil uji T didapatkan nilai p-value <0,05. Hasil penelitian dapat disimpulkan bahwa terdapat perbedaan yang signifikan antara pengaruh filter dalam pembuatan komponen Packed Red Cell Leucodepleted (PRC LD) terhadap nilai leukosit.References
Bojonegoro, R. C., Dewi, C. C., Muflikhah, N. D., & Nuraini, F. R. (2023). 3 1,2,3. 3(1).Buku Ajar Mata Kuliah. (N.D.).
Care, J. H., Transfusi, T., Leukodepleted, D., & Pasien, P. (2020). Terapi Transfusi Darah Leukodepleted Pada Pasien Thalassemia. 5(2), 423–435.
Cherian, M. N., & Emmanuel, J. C. (2002). Clinical Use Of Blood. Update In Anaesthesia, 14, 18–22.
Council Of Europe. (2020). Guide To The Preparation, Use And Qualit Assurance. Guide To The Preparation, Use And Qualit
Farida Nur Aini, Martati Nur Utami, B. S. L. (2020). Komponen Darah. Journal Of Chemical Information And Modeling, 53(9), 1689–1699.
Kamilah, D., & Widyaningrum, D. (2019). Ditransfusikan Dengan Reaksi Transfusi Febrile Non Haemolytic Transfusion Reaction ( FNHTR ). 10(1), 227–231. Https://Doi.Org/10.1556/Ism.V10i1.348
Maharani, E. A., & Noviar, G. 2018. Imunohematologi dan Bank Darah. Kementrian Kesehatan Republik Indonesia, 11(3), 322. https://www.mculture.go.th/mculture_th/download/king9/Glossary_about_HM_King_Bhumibol_Ad ulyadej’s_Funeral.pdf
Ningrum, N. R., Khairinisa, G., Prodi, D., Laboratorium, T., Ilmu, F., Kesehatan, T., Jenderal, U., Yani, A., Buffy, P. R. C., Removed, C., Cell, W. R., & Hematologi, P. (2022). Gambaran Hematologi Pada Komponen PRC Buffy Coat Removed Dan Washed Red Cell. 8(1), 70–79.
Organization, W. H. (2022). Availability , Safety And Quality Of Blood Products. April, 1–4. Availability , Safety And Quality Of Blood Products. April, 1–4.
Permenkes. 2015. ‘Peraturan menteri kesehatan republic indonesia nomor 91 Tahun 2015 tentang standar pelayanan transfusi darah.
The American Cancer Society. (2016). Blood Transfusion And Donation Blood Transfusions For People With Cancer. American Cancer Society, Iv, 1–28.
Urias, E. V. R., De Freitas Teles, L., Lula, J. F., Rocha, C. U., Pereira, I. A., Givisiez, F. N., Viana, A. G., De Cássia Moreira Soares, T., & Carvalho, S. F. G. (2021). Leukocyte Filters: A Review Of The Mechanisms And Applications In Hemotherapy. Revista Da Associacao Medica Brasileira, 67(7), 1056–1060. Https://Doi.Org/10.1590/1806-9282.20210383
With, C., Prc, L., Utd, A. T., & City, S. (2021). Perbedaan Kadar Leukosit Pengolahan Komponen Darah Prc Konvensional Dengan Prc Leucodepleted Di Utd Pmi Kota Surabaya Program Studi D-Iii Teknologi Bank Darah , Fakultas Ilmu Kesehatan Universitas Dr . Soetomo Surabaya. 16(2), 92–98. Https://Doi.Org/10.36086/Jpp.V16i1.489
World Health Organization and International Federation of Red Cross and Red Crescent Societies. (2010). Towards 100 % Voluntary Blood Donation A Global Framework for Action. World Health, 123.
Wahidiyat, P. A., & Adnani, N. B. 2017. Transfusi Rasional pada Anak. Sari Pediatri, 18(4), 325. https://doi.org/10.14238/sp18.4.2016.325-31 https://doi.org/10.14238/sp18.4.2016.325-31
WHO, 2016. Donor Selection: Guidelines on Assessing Donor, Suitability for Blood Donation; 2012.. Diakses tanggal 8 Januari 2023 pukul 22.00 WIB
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Syarifah Syarifah, Theresia Nona Arni
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).